Pediatrics

FDA Updates: Approvals in Rare Disorders; Expanded Approval for Flu Treatment

November 29, 2020

FDA approves several drugs to treat rare conditions in both cancer and metabolic diseases.

FDA Updates: Treatment for Duchenne Mutation, Gilead Seeks Remdesivir Approval, Data on ALKS 3831

August 16, 2020

Actions from FDA this week include approval of a second targted treatment for a Duchenne muscular dystrophy mutation, and filings in COVID-19 and blood disorders.

FDA Updates: Assays Used in Cancer Care Get Green Light

August 09, 2020

Adaptive Biotechnologies’ clonoSEQ gets third approval; FDA also acts on first at-home treatment for spinal muscular atrophy.

Hospital CEO Keeps Pediatric Care Local

July 15, 2018

This month’s featured exec is Deborah Feldman, president and CEO of Dayton Children’s Hospital. Here, she sheds light on how the future of healthcare is shaping up, and how value-based care, the ACA, and pediatric pain management fit in.

Medical science sure to help us live longer

October 01, 2006

Would you pay $19,900 to add another year to your life? If only it were that simple. The New England Journal of Medicine (NEJM) recently published a study that concluded between 1960 and 2000, we paid an average of $19,900 in medical costs per year of life gained during that time. In 1960, a newborn's life expectancy was 69.9 years, and in 2000, it was 76.87 years, according to the study.

Rural access route: E-health investments and network of support facilities help connect rural residents to high-quality care

September 01, 2006

Telemedicine programs decrease time-to-diagnosis, save financial resources and reduce hospital stays.

Medicaid and uninsured as percent of pediatric emergency department* visits in certain markets, 2004

September 01, 2006

Medicaid and uninsured as percent of pediatric emergency department* visits in certain markets, 2004

Pediatric emergency department* visit growth by acuity and payer type, 2004

August 01, 2006

Pediatric emergency department visit growth by acuity and payer type, 2004

Infusion of advanced vaccines: Medications that change history also present logistical questions

July 01, 2006

Drug Manufacturers have introduced vaccines for meningococcal disease, shingles, pertussis, rotavirus, and cervical cancer, meanwhile even more vaccines are in the development pipeline. While each represents a major step forward for public health, the advances present an assortment of challenges from payment rates for physicians to moral issues for parents.

Politics aside, we have a chance to prevent a deadly cancer

July 01, 2006

About two hours after a colleague and I lamented over breakfast about Americans' shortcomings in wellness, I heard the news that the vaccine for human papillomavirus (HPV) had received the final nod from FDA. Now there was something Americans were actually doing pretty well: immunizing.